Complementary use of passive surveillance and Mini-Sentinel to better characterize hemolysis after immune globulin-Reference-Cited by-同舟云学术

Complementary use of passive surveillance and Mini-Sentinel to better characterize hemolysis after immune globulin

Published:2015-07 Issue:S2 Volume:55 Page:S28-S35
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Winiecki Scott¹,Baer Bethany¹,Chege Wambui¹,Jankosky Christopher¹,Mintz Paul²,Baker Meghan³⁴,Woodworth Tiffany³,Nguyen Michael¹

Affiliation:

1. Division of Epidemiology, Office of Biostatistics and Epidemiology; Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA); Silver Spring Maryland

2. Division of Hematology Clinical Review, Office of Blood Research and Review; Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA); Silver Spring Maryland

3. Department of Population Medicine; Harvard Medical School and Harvard Pilgrim Health Care Institute; Boston Massachusetts

4. Division of Infectious Diseases, Department of Medicine; Brigham and Women's Hospital; Boston Massachusetts

Funder

U.S. Food and Drug Administration

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.13116/fullpdf

Reference29 articles.

1. The use of intravenous immune globulin in immunodeficiency diseases;Buckley;N Engl J Med,1991